Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
12/2006
12/14/2006US20060282908 Identification of the genetic determinants of the polymorphic CYP3A5 expression
12/14/2006US20060281911 Thermolabile hydroxyl protecting groups and methods of use
12/14/2006US20060281909 Sequence-determined DNA fragments encoding SRF-type transcription factor proteins
12/14/2006US20060281908 Xylose isomerases, nucleic acids encoding them and methods for making and using them
12/14/2006US20060281907 Halogenated aminoquinolines and methods for forming DNA triplexes
12/14/2006US20060281902 Human signal peptide-containing proteins
12/14/2006US20060281901 Method for the production of amyloid-beta peptide using ubiquitin
12/14/2006US20060281900 Lepidoptera voltage-gated calcium channels
12/14/2006US20060281899 Mutants of biotin binding protein
12/14/2006US20060281701 antisense antiviral compounds and methods of their use and production in inhibition of growth of viruses of the Filoviridae family, and in the treatment of a viral infection. The compounds and methods relate to the treatment of viral infections in mammals including primates by Ebola and Marburg viruses.
12/14/2006US20060281698 a single-stranded antisense oligonucleotide, targeted to nucleic acid encoding lipid-free protein constituents of plasma lipoproteins, used for diagnosis and therapy of cardiovascular disorders, including myocardial infarction and atherosclerosis
12/14/2006US20060281697 Methods and kits for diagnosing and treating b-cell chronic lymphocytic leukemia
12/14/2006US20060281696 Decoy-oligonucleotide-inhibition of cd40-expression
12/14/2006US20060281679 Human FGF-23 gene and gene expression products
12/14/2006US20060281676 Agent and method for the treatment and prevention of tse and method for the production of said agent
12/14/2006US20060281672 Dec-205 (ly 75)/dcl-1 intergenic splice variants associated with hodgkin's disease, and uses thereof
12/14/2006US20060281175 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
12/14/2006US20060281151 Globular Adiponectin Variants
12/14/2006US20060281150 Preparing membrane receptors from extracellular baculoviruses
12/14/2006US20060281149 Transforming growth factor-beta-related molecules and uses thereof
12/14/2006US20060281148 Cell-free extracts and synthesis of active hydrogenase
12/14/2006US20060281147 Thrombin-like recombinant baxtroxobin expressed by pichia sp.and production method thereof
12/14/2006US20060281146 Novel compositions and methods for the treatment of immune related diseases
12/14/2006US20060281133 Targeted fusion proteins and methods for the characterization of cellular membrane domains
12/14/2006US20060281127 Promoter sequences for urocortin II and the use thereof
12/14/2006US20060281125 ICBP90 polypeptide and its fragments and polynucleotides coding for said polypeptides and applications for diagnosing and treating cancer
12/14/2006US20060281123 Polynucleotide comprising single-nucleotide polymorphism associated with colorectal cancer, microarray and diagnostic kit comprising the same, and method of diagnosing colorectal cancer using the same
12/14/2006US20060281117 Alternatively spliced isoform of calcium channel, voltage dependent, alpha-1G subunit (CACNA1G)
12/14/2006US20060281115 MAX quadruplex nucleic acids and uses thereof
12/14/2006US20060281114 Methods and compositions for assessment of pulmonary function and disorders
12/14/2006US20060281110 Methods to identify antimicrobial compounds that interrupt ribosome biogenesis
12/14/2006US20060281109 Polymerases
12/14/2006US20060281107 consists of between 2 and 60 different probe sets wherein at least 20% of the different probe sets comprise one or more isolated polynucleotides that selectively hybridize to a genomic region
12/14/2006US20060281106 Using polymerase regulatory sequences as evaluative tool in identifying modulators for treatment of cell proliferative disorders
12/14/2006US20060281100 Thiotriphosphate nucleotide dye terminators
12/14/2006US20060281096 Methods and kits for detecting genetically modified organism (GMO)
12/14/2006US20060281095 44 human secreted proteins
12/14/2006US20060281089 Detecting presence of mutant bcl gene of given sequence; identifying patients resistant to chemotherapy or radiation treatments
12/14/2006US20060281088 Markers for lxr activation
12/14/2006US20060281084 Method of detecting bifidobacterium infantis
12/14/2006US20060281081 Method of diagnosing colon and gastric cancers
12/14/2006US20060281080 Novel lipases and uses thereof
12/14/2006US20060281078 Human fast-1 gene
12/14/2006US20060281070 Synthetic genetic expression cassette comprising human preproenkephalin sequences for use in treating neuropathic pain
12/14/2006US20060280780 Antimicrobial polypeptides
12/14/2006US20060280750 Anti-idiotypic antibodies which recognise the idiotope of an antibody specific for a yeast killer toxin possess microbicidal activity
12/14/2006US20060280749 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor
12/14/2006US20060280747 capable of binding to mouse Vascular endothelial cell growth factor (VEGF) and human VEGF; cancer, diabetes related diseases, edema, inflammation
12/14/2006US20060280743 Immunoglobulin for treatment of alzheimer's diseases
12/14/2006US20060280734 Retargeting
12/14/2006US20060280731 Novel substrate for Rpn11 enzymatic activity
12/14/2006US20060280728 Trimeric OX40-immunoglobulin fusion protein and methods of use
12/14/2006CA2725709A1 Susceptibility genes for age-related maculopathy (arm) on chromosome 10q26
12/14/2006CA2614295A1 Transcription factor decoy
12/14/2006CA2610405A1 Mannitol induced promoter systems in bacterial host cells
12/13/2006EP1731525A1 Nucleotide derivatives and dna microarray
12/13/2006EP1731144A1 Identification of genes altered in multiple myeloma
12/13/2006EP1730310A2 A formulation for increasing endogenous adiponectin and leptin production
12/13/2006EP1730309A2 Compositions and methods for optimizing cleavage of rna by rnase h
12/13/2006EP1730307A2 Photocleavable fluorescent nucleotides for dna sequencing on chip constructed by site-specific coupling chemistry
12/13/2006EP1730305A2 Nucleic acid complexes
12/13/2006EP1730286A2 Therapeutic anti-cancer dna
12/13/2006EP1730281A2 Immunostimulatory nucleic acids for inducing il-10 responses
12/13/2006EP1730161A2 Hybridization chain reaction
12/13/2006EP1730160A2 Neoplasia diagnostic compositions and methods of use
12/13/2006EP1730158A2 Methods and compositions for in vitro and in vivo use of parallel stranded hairpins and triplex structures as nucleic acid ligands
12/13/2006EP1729810A2 Methods of reducing aggregation of il-1ra
12/13/2006EP1729801A2 Mutant viral nucleic acids and vaccine containing same
12/13/2006EP1729800A2 Immunogenic compositions for chlamydia pneunomiae
12/13/2006EP1615670A4 Targets for tumor growth inhibition
12/13/2006EP1440079B1 Acyclic linker-containing oligonucleotides and uses thereof
12/13/2006EP0981650B1 Molecular detection of chromosome aberrations
12/13/2006EP0792375B9 Enzymatic dna molecules
12/13/2006EP0760602B1 Use of fas ligand to suppress lymphocyte-mediated immune responses
12/13/2006CN1878871A IL-1 receptor based antagonists and methods of making and using
12/13/2006CN1878789A Human cathelicidin antimicrobial peptides
12/13/2006CN1878785A Delta12 desaturases suitable for altering levels of polyunsaturated fatty acids in oleaginous yeast
12/13/2006CN1878784A Motoneuronotrophic factor gene sequences
12/13/2006CN1876814A Design and preparation of certain-length single chain polyA RNA molecule and application thereof
12/13/2006CN1289690C Methods and compositions for amplification of RNA sequences
12/13/2006CN1289520C CpG-containing single chain deoxy-oligonucleotide having anti-influenza virus
12/13/2006CN1289519C Detection and identification of enteric bacteria
12/12/2006US7148401 Transforming at least one cell of a plant with an expression cassette comprising a promoter operably linked to a polynucleotide of interest, regenerating said transformed cell into a transformed plant;wherein said promoter drives the expression of polynucleotide of interest preferentially in elongation
12/12/2006US7148398 Disease resistance
12/12/2006US7148343 A formulation for isolating and purifying nucleic acids (RNA): a lithium salt at a concentration of at least about 1 M, a detergent, and a buffer
12/12/2006US7148342 Compositions and methods for sirna inhibition of angiogenesis
12/12/2006US7148341 Adenovirus associated nucleotide sequences; for use as gene transfer tool in genetic engineerinf in the
12/12/2006US7148340 Thermus thermophilus nucleic acid polymerases
12/12/2006US7148339 Temperature sensitive mutant of bacteriophage T4 endonuclease VII
12/12/2006US7148338 Comprises nucleotide sequences coding oligopeptidase for use in screening compounds for treatment of cell proliferative and metabolic disorders; enzyme inhibitors
12/12/2006US7148337 drug target and diagnostic marker for prostate cancer; host cells and expression vectors
12/12/2006US7148336 Nucleic acid sequences and methods of use for the production of plants with modified polyunsaturated fatty acid levels
12/12/2006US7148205 Intravascular delivery of non-viral nucleic acid
12/12/2006US7148204 An antisense compound 8 to 30 nucleobases in length targeted to a 3'-untranslated region, a stop codon region, a coding region, or a 5'-untranslated region of a nucleic acid molecule encoding human bcl-x gene or protein
12/12/2006US7148203 Plasmid for use in gene expression, mapping and mutagenesis; transposases
12/12/2006US7148053 Transgenic yeast cells coding membrane receptor proteins for diagnosis and treatment of pancreatitis, pancreatic cancer, gastrointestinal disorders and irritable bowel disease
12/12/2006US7148052 Nucleic acid encoding β-1,3-glucanase from lily
12/12/2006US7148051 Conversion of hydroxy nitriles to carboxylic acids with nitrilase genes
12/12/2006US7148050 method of screening for agents which decrease extracellular matrix degradation; test compound which binds to the proteine kinase-like protein polypeptide is thereby identified as a potential agent for decreasing extracellular matrix degradation
12/12/2006US7148048 Elution through a chromatography column, using a hydroxyapatite column; biological injection, treating genetic disorders